Antimicrobial Resistance

Newest Oldest Showing 1-4 of 4 results
Original Article / VOLUME 3, ISSUE 1, APRIL 2021

The role of Isolation of the Patients on Hospital Admission for Prevention of Nosocomial Infections

Şiran Keske and others

Healthcare-associated infections (HAI) is an increasing global problem all over the world. Multidrug-resistant (MDR) pathogens, including carbapenem-resistant Gram-negative Enterobacterales, Pseudomonas spp. and Acinetobacter spp. have become common causes of HAI, such as central line-associated bloodstream infections (BSIs), catheter-associated urinary tract infections (UTIs), surgical site infections (SSIs) and ventilatory associated pneumonia (VAPs). These infections increase not only mortality but also healthcare Read More

Original Article / VOLUME 2, ISSUE 3, DECEMBER 2020

Effectiveness of Surgical Prophylaxis Where the Antibiotic Resistance is High

Mehtap Aydın and others

Surgical site infections (SSI) are defined as infections that occur up to 30 days or one year after surgery in patients with implants, affecting the incision or deep tissue at the surgery site. They account for 20% of all healthcare-associated infections (HAI) in hospitalized patients. Patients with SSI are hospitalised additionally 7-11 days postoperatively. Read More

Original Article / VOLUME 2, ISSUE 2, AUGUST 2020

Antimicrobial Resistance and Molecular Patterns in Community-acquired Complicated Intra-abdominal Infections: A Multicentric Study

Vildan Avkan-Oğuz and others

Complicated intra-abdominal infection (cIAI) is defined as localized or diffuse peritonitis with the involvement of multiple intraperitoneal organs. Source control and appropriate empirical antibiotics are essentials of the treatment. There are few clinical and microbiologic studies regarding cIAI in Turkey. Empiric antibiotics were selected due to diagnoses; community-acquired IAI (CA-IAI) or healthcare-associated IAI. Guidelines published on this topic lack definitive criteria for CA-IAI. Read More